Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Qvist

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Gastroenterology|September 28, 1999
An experimental pain model based on electric stimulations of the colon mucosaA M Drewes, P Petersen, P Qvist, et al.
Scandinavian Journal of Gastroenterology|October 9, 2001
Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorptionM Montagnani, M W Love, P Rössel, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|October 1, 1990
Flow cytometric detection of bovine viral diarrhea virus in peripheral blood leukocytes of persistently infected cattleP Qvist, B Aasted, B Bloch, et al.
Veterinary Microbiology|January 1, 1992
A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniaeN C Feld, P Qvist, P Ahrens, et al.
Osteoarthritis and Cartilage|September 5, 2008
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRIE B Dam, I Byrjalsen, M A Karsdal, et al.
The Journal of Biological Chemistry|April 11, 1997
Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) regionC Fledelius, A H Johnsen, P A Cloos, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a reviewE U Sumer, S Schaller, B C Sondergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1997
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagenM Bonde, P Garnero, C Fledelius, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 25, 2006
Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseasesK Henriksen, L B Tanko, P Qvist, et al.
Clinical Chemistry|November 4, 1998
Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagenC Rosenquist, C Fledelius, S Christgau, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Gastroenterology|September 28, 1999
An experimental pain model based on electric stimulations of the colon mucosaA M Drewes, P Petersen, P Qvist, et al.
Scandinavian Journal of Gastroenterology|October 9, 2001
Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorptionM Montagnani, M W Love, P Rössel, et al.
Canadian Journal of Veterinary Research = Revue Canadienne De Recherche Veterinaire|October 1, 1990
Flow cytometric detection of bovine viral diarrhea virus in peripheral blood leukocytes of persistently infected cattleP Qvist, B Aasted, B Bloch, et al.
Veterinary Microbiology|January 1, 1992
A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniaeN C Feld, P Qvist, P Ahrens, et al.
Osteoarthritis and Cartilage|September 5, 2008
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRIE B Dam, I Byrjalsen, M A Karsdal, et al.
The Journal of Biological Chemistry|April 11, 1997
Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) regionC Fledelius, A H Johnsen, P A Cloos, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a reviewE U Sumer, S Schaller, B C Sondergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1997
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagenM Bonde, P Garnero, C Fledelius, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 25, 2006
Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseasesK Henriksen, L B Tanko, P Qvist, et al.
Clinical Chemistry|November 4, 1998
Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagenC Rosenquist, C Fledelius, S Christgau, et al.
Pageof 6